glp 1 history of pancreatitis GLP-1–Based Therapies: The Dilemma Uncertainty Why Does GLP-1 Cause Pancreatitis?
Description
no affiliation
Short-acting GLP-1 RAs, exenatide and lixisenatide, are associated with a transient (112 h) mean placebo- and baseline-adjusted 24-h HR increase of 13 beats per minute (bpm)
While GLP-1 receptor agonists like tirzepatide and semaglutide have revolutionized obesity treatment, emerging evidence suggests that strategic compounding with complementary agents
ICD-10 codes to identify the outcome are included in supplementary table S1
Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial
